
Scegli la tua etichetta
mostrata direttamente sul flaconcinoACE-031
Muscle Building
- Spedito dalla Germania
Ordine
- DHL con tracciamento
- Imballaggio discreto
In sintesi
ACE-031 in cifre
I dati chiave dalla nostra enciclopedia.
Voce completa dell'enciclopedia- Class
- ActRIIB-Fcmyostatin/activin trap
- Half-life
- longfusion protein
- Use
- Subcutaneousno established protocol
- Sizes
- 1 mg1 size in the shop
What studies show
All 2 sources in the lexicon- Attie et al., Muscle & Nerve, 2013
ACE-031 in boys with Duchenne muscular dystrophy (study stopped early) (opens in a new tab)
Campbell et al., Muscle & Nerve, 2017
Non esiste ancora un'analisi di laboratorio per ACE-031. Vota a favoreFallo testare tu, noi paghiamo la metàTutte le analisi di laboratorio
Conoscenze
Tutto su ACE-031
Informazioni dettagliate in arrivo.
Utili da avere
Cosa ti serve insieme
L'acqua batteriostatica viene aggiunta automaticamente al carrello. Siringhe e tamponi con un clic.
Siringhe da insulina
10 pz · 5.50 €
Tamponi imbevuti di alcol
50 pz · 10 €
Quanta acqua?
Unità sulla siringa per la misura del tuo flaconcino.
Apri il calcolatore →What is ACE-031?
A large fusion protein: the outer part of the activin receptor IIB, linked to a piece of an antibody (IgG1 Fc). It binds myostatin and related messengers in the blood before they reach the receptor on muscle. The compound name is ramatercept.
What did the first human study show?
48 healthy postmenopausal women received a single dose at ascending levels or placebo. In the group with the highest study dose lean mass rose by 3.3 percent and thigh muscle volume by 5.1 percent after 29 days. The half-life was 10 to 15 days.
Why was development stopped?
In the trial in boys with Duchenne muscular dystrophy nosebleeds and telangiectasias occurred, meaning widened small blood vessels. The trial was stopped after the second dosing regimen because of potential safety concerns. The activin receptor IIB acts not only on muscle but also on vessels.
Was there a benefit in Duchenne?
Only trends. The 6-minute walk distance tended to be maintained in the ACE-031 groups while it declined on placebo. There were also trends towards more lean mass and bone density and less fat mass. None of this was statistically significant.
Is ACE-031 approved?
No. ChEMBL lists ramatercept with phase 2 as the highest phase. ClinicalTrials.gov lists four trials from 2008 to 2011, both phase 2 trials were terminated early (as of 26 October 2026).
What do animal studies show?
In marmosets lean mass increased over 14 weeks on ACE-031, muscle fibres became thicker and muscle force rose. This did not happen in the control group. The authors see this as a pointer for muscle diseases in humans.
Correlati
Prodotti correlati
IGF-1 LR3
Peptidi · Crescita e muscoli Crescita e muscoli
2 misure
= da 11.6 €/fiala
MGF
Peptidi · Crescita e muscoli Crescita e muscoli
1 misura
= 13.2 €/fiala
PEG-MGF
Peptidi · Crescita e muscoli Crescita e muscoli
1 misura
= 22 €/fiala
FST-344 (Follistatin)
Peptidi · Crescita e muscoli Crescita e muscoli
1 misura
= 53.2 €/fiala
ACE-031